<?xml version="1.0" encoding="UTF-8"?>
<ref id="b72-dic-2020-4-15">
 <label>72</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Borba</surname>
    <given-names>MGS</given-names>
   </name>
   <name>
    <surname>Val</surname>
    <given-names>FFA</given-names>
   </name>
   <name>
    <surname>Sampaio</surname>
    <given-names>VS</given-names>
   </name>
   <name>
    <surname>Alexandre</surname>
    <given-names>MAA</given-names>
   </name>
  </person-group>
  <article-title>Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb cl</article-title>
  <source>medRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.04.07.20056424</pub-id>
 </element-citation>
</ref>
